ABVC BioPharma, Inc. (ABVC) stock
ABVCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ECOC
$0.96−0.03 (-3.03%)
Close on Nov 12, 2026Market cap $25.59MP/E –Yield –
ABVC BioPharma gross margin
Gross margin is gross profit as a percentage of revenue.
ABVC BioPharma's gross margin for the twelve months ending Dec 31, 2024 was 171.9%. For fiscal 2024 it was 171.9%, against -98.1% the year before. The highest annual figure on record is 171.9% in fiscal 2024.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 171.9% | +270.0 |
| FY2023 | Dec 31, 2023 | -98.1% | −168.6 |
| FY2022 | Dec 31, 2022 | 70.5% | −28.1 |
| FY2021 | Dec 31, 2021 | 98.6% | +2.4 |
| FY2020 | Dec 31, 2020 | 96.1% | −1.0 |
| FY2019 | Dec 31, 2019 | 97.1% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | 100.0% | +23.0 |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | 100.0% | +6429.8 |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | 99.9% | +186.4 |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | 99.8% | +1194.5 |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | 77.0% | +24.0 |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | -6329.8% | −6384.8 |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | -86.4% | −161.0 |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | -1094.6% | −1192.0 |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | 53.0% | −39.6 |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | 54.9% | −44.7 |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | 74.6% | −23.4 |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | 97.3% | −2.2 |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | 92.6% | −4.3 |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | 99.6% | +7.1 |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | 97.9% | −0.2 |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | 99.5% | +4.6 |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | 96.9% | −0.6 |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | 92.5% | −6.0 |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | 98.1% | +5.1 |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | 95.0% | −4.3 |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | 97.5% | −2.5 |
| Q3 FY2019CQ3 2019 | Sep 30, 2019 | 98.6% | −1.4 |
| Q2 FY2019CQ2 2019 | Jun 30, 2019 | 93.0% | – |
| Q1 FY2019CQ1 2019 | Mar 31, 2019 | 99.3% | – |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | 100.0% | – |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | 100.0% | – |
See a number that looks wrong?